Loading clinical trials...
Loading clinical trials...
A Multi-center, Double-blind, Randomized, Vehicle-controlled, Parallel-group Study Comparing Metronidazole Gel 1%, to Metrogel® (Metronidazole Gel) 1% in the Treatment of Rosacea
Conditions
Interventions
Reference: Metronidazole Gel 1%
Test: Metronidazole Gel 1%
+1 more
Locations
27
United States
Los Angeles, California, United States
San Diego, California, United States
Boca Raton, Florida, United States
Clearwater, Florida, United States
Miami, Florida, United States
Miami, Florida, United States
Start Date
February 1, 2015
Primary Completion Date
July 1, 2015
Completion Date
October 1, 2015
Last Updated
September 3, 2020
NCT01872715
NCT01494467
NCT04608500
NCT00855595
NCT03263273
NCT01933464
Lead Sponsor
bioRASI, LLC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions